Nathan D. Wong, PhD, FACC, FAHA, FASPC, FNLA

Professor and Director, Heart Disease Prevention Program

Division of Cardiology, University of California, Irvine

Adjunct Professor of Epidemiology (UCLA and UC Irvine) and Population Sciences (UC Irvine)

Past President, American Society for Preventive Cardiology

C240 Medical Sciences

Irvine, CA 92697-4079, USA

T: 949-824-5561

Email: [...]

Ezra A. Amsterdam, MD, FACC, FAHA

Distinguished Professor of Medicine

Associate Chief, Division of Cardiovascular Medicine

Past President, American Society for Preventive Cardiology

Department of Internal Medicine

University of California (Davis) Medical Center

4086 Y Street

Sacramento, CA 95817, USA

T: 916-734-5191

Email: [...]

Peter P. Toth, MD, PhD, FAAFP, FCCP, FNLA, FASPC, FESC, FACC

Professor of Clinical Family and Community Medicine

University of Illinois School of Medicine

Adjunct Associate Professor of Medicine

Ciccarone Center for Cardiovascular Disease Prevention, Johns Hopkins University

101 East Miller Road

Sterling, IL 61081, USA

Email: Peter.[...]

Focuses on communication and implementation of latest guidelines for cardiovascular disease prevention

Examines psychosocial stress, family history, nutrition, physical activity, smoking, and alcohol use

Covers all major and important emerging cardiovascular risk factors, key methodologies in risk assessment, and special issues regarding specific patient populations

Discusses prevention of coronary heart disease, heart failure, peripheral arterial disease, atrial fibrillation, ischemic stroke, and other cardiovascular diseases

Chapter. 1: Focus on Cardiovascular Health Promotion and Disease Prevention- Opportunities for Improvement.- Chapter. 2: National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk.- Chapter. 3: Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors.- Chapter. 4: Assessment and Management of Psychosocial Risk Factors within Preventive Cardiology Practice.- Chapter. 5: Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction.- Chapter. 6: Physical Activity Strategies.- Chapter. 7: Obesity Management and Prevention of Cardiovascular Disease.- Chapter. 8: Smoking and Vaping.- Chapter. 9: Alcohol and Cardiovascular Diseases.- Chapter. 10: The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: A personalized approach to risk reduction.- Chapter. 11: Blood Pressure and Hypertension Management.- Chapter. 12: Cardiodiabetology: Reducing Risks to Optimize Cardiovascular Disease Outcomes.- Chapter. 13: Antiplatelet Therapy.- Chapter. 14: Inflammation and Atherosclerotic Cardiovascular Disease.- Chapter. 15: The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests.- Chapter. 16: Exercise Electrocardiographic Stress Testing.- Chapter. 17: Ultrasound and MRI Assessment of Cardiovascular Risk.- Chapter. 18: Role of CT Coronary Calcium Scanning and Angiography in Evaluation of Cardiovascular Risk.- Chapter. 19: Cardiovascular Disease Prevention in Women.- Chapter. 20: Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease.- Chapter. 21: Prevention of Heart Failure.- Chapter. 22: Prevention of Peripheral Arterial Disease.- Chapter. 23: Prevention of Atrial Fibrillation.- Chapter. 24: Prevention of Ischemic Stroke.- Chapter. 25: Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.- Chapter. 26: Primary Prevention of Cardiovascular Disease Guidelines.- Chapter. 27: Secondary Prevention and Cardiac Rehabilitation.- Chapter. 28: Integrative Approaches for Cardiovascular Disease Prevention.- Chapter. 29: Preventive Cardiology as Specialized Medical Art.